Navigation Links
Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C
Date:11/2/2007

ized into three groups to receive either 48 weeks of standard of care treatment (n=40), 12 weeks of nitazoxanide followed by 36 weeks of nitazoxanide plus peginterferon (a dual regimen, n=28), or 12 weeks of nitazoxanide followed by 36 weeks of nitazoxanide plus standard of care treatment (a triple regimen, n=28). An additional 24 interferon-experienced patients were randomized to receive 12 weeks of nitazoxanide followed by either the dual regimen (n=12) or the triple regimen (n=12) for 36 weeks. Patients received 180 microgram injections of pegylated interferon (Pegasys(R)) once per week; nitazoxanide was administered as one 500 mg tablet twice daily; and ribavirin was administered as 1,000 or 1,200 mg daily according to weight.

Results

At 12 weeks following the end of treatment, naive patients who received a triple regimen that included standard of care and nitazoxanide showed a significantly higher SVR (HCV RNA <10 IU/mL, Abbott m2000) than the group receiving the standard of care regimen (79% vs. 43%, respectively) (p=0.006). The data also suggest a potential for eliminating or reducing the role of ribavirin in treating hepatitis C. Patients treated with a dual regimen of nitazoxanide and peginterferon showed an SVR at week 12 following the end of treatment that was not inferior to standard of care (68% vs. 43%, respectively) (+25%; 95% CI: -1%, +47%). Of 24 treatment-experienced patients, the triple regimen (n=12) resulted in an SVR of 25% at week 12 post- treatment, and the dual regimen group (n=12) had an SVR of 8%.

"Results from this trial validate a new approach to treating HCV that focuses on the interaction between the virus and the cell," said Jean-Francois Rossignol, M.D., Director of the Romark Institute for Medical Research. "With confirmation provided by this data we are aggressively pursuing development of nitazoxanide and related drugs to treat chronic hepatitis C and other viral diseases."

Nitazoxanide is the first of a ne
'/>"/>

SOURCE Romark Laboratories
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. FDA approves Phase 0 trial which tests experimental drugs on humans
2. SARS-Free Taiwan to Mark End Phase of Global Fight
3. S. Africa AIDS in death phase
4. Spray on contraceptive clears Phase I trial
5. Phase 3 trials of two multi-kinase inhibitors against cancer
6. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
7. Phase II trails of new HIV vaccine to be held in South Africa
8. Phase 1 Drug Trials on Humans to Be Made Public
9. Jalgaon: Third Phase Of Culling Operations Begin
10. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
11. Cadila to Commence Phase I Clinical Trials On ZYH2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... (PRWEB) April 18, 2015 In the ... a couple of changes. , "We had to run ... make needed changes," said Jennifer Ramirez, the PR Director. ... happy to say that we are back on track ... in the process of changing phone systems which has ...
(Date:4/18/2015)... April 18, 2015 “ ArcAngel ” was ... takes a look at the latest and coolest ... Troohey, the host of AppWatch and technology expert, conducted the ... personal safety app. , In a turbulent world, people ... Calling 911 should always be their first move, but some ...
(Date:4/17/2015)... John Evans, a Gardant affordable assisted living community, ... p.m. to 3 p.m. on April 24. , The ... Pekin, Illinois, serves older adults of all incomes, including ... their independence. , Becky Baker will entertain guests on ... during the luau. , For more information, call 309-477-8800. ...
(Date:4/17/2015)... 2015 Alcohol and Violence , The ... that drinking and driving has been the focus of ... time, the link between alcohol and crime received less ... violence and sexual assault, and their relationship to alcohol ... 5.3 million adults in America were drinking alcohol at ...
(Date:4/17/2015)... Washington, D.C. (PRWEB) April 17, 2015 ... today issued the following statement: “On Wednesday April 15th, ... bodies and adopted a resolution recognizing the Armenian Genocide, ... the memory of the one-and-a-half million innocent Armenian victims ... of Christians (IDC) extols the EU for this timely ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Temporary Number Available 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3
... July 30, 2009 The typical dose of a ... too low to account for modern-day physiques, UT Southwestern ... reported online and in the August edition of ... those living in societies plagued by obesity, said Dr. ...
... , , SAN DIEGO, July 29 ... a real estate investment trust focused on Providing Real Estate to the Life ... June 30, 2009. , , Highlights: , , ... million, up 21.6% from $70.8 million for the same period in 2008, driven ...
... KING OF PRUSSIA, Pa., July 29 Health Market ... anticipated product for the master data management market. ... segments including life sciences, payer, pharmacy benefits management and ... available for complete customer master data management. , ...
... July 29 As you continue to cover the House healthcare ... to speak with you about this subject. Below is a statement ... in the Department of Health Policy at George Washington University Medical ... in the House, also known as the Blue Dogs, have reached ...
... , , PORTLAND, Ore., July 29 ... Regence was recognized for its work to engage consumers to transform ... "Transforming the Health Care System - Engaging Consumers to Create Value-Driven ... awards from Summit International and from Healthcare Marketing Report,s Annual Healthcare ...
... 0.3 percent, chances of serious complications 4.3 percent, , ... bariatric surgery to combat significant obesity, a new study ... than what has previously been reported. , The study, ... adjustable gastric banding (lap-band surgery), found that the risk ...
Cached Medicine News:Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 2Health News:Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report 3Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 2Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 3Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 4Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 5Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 6Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 7Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 8Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 9Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 10Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 11Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 12Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 13Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 14Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 15Health News:BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results 16Health News:Health Market Science Unveils CompleteView, the Most Comprehensive Master Data Management (MDM) Solution Available in the Healthcare Market 2Health News:Health Market Science Unveils CompleteView, the Most Comprehensive Master Data Management (MDM) Solution Available in the Healthcare Market 3Health News:'It's Still Too Early to Be Popping Champagne Corks' - Expert to Comment on Health Care Reform- House Healthcare Proposal 2Health News:Regence Wins Awards for Consumer Appeal to Transform Health Care 2Health News:Study Finds Weight-Loss Surgery Safer Than Thought 2Health News:Study Finds Weight-Loss Surgery Safer Than Thought 3
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/vrd3bd/mammography ) has announced ... Strategic Business Report" report to their offering. ... Equipment in US$ Thousands by the following Product Segments: ... provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ...
(Date:4/17/2015)... , Apr. 16, 2015 Research and Markets ... of the "Corporate Reputation of Pharma in 2014 ... edition" report to their offering. This ... from 130 patient groups with an interest in diabetes ... (and of the pharma industry as a whole) in ...
(Date:4/17/2015)... Australia , April 17, 2015 Bionomics ... discovery and development of innovative therapeutics for the treatment ... today announced the presentation of data from three of ... Association for Cancer Research (AACR) 106 th Annual ... Philadelphia, PA USA. ...
Breaking Medicine Technology:Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5
... YORK, Dec. 8, 2010 Reportlinker.com announces that ... its catalogue: Global Generic Pharmaceuticals ... The Global Generic Pharmaceuticals Industry Report ... evaluation of the Global Generic Pharmaceuticals Industry Report. ...
... Ill., Dec. 8, 2010 Life Spine announced today ... the OCTAVE Posterior Fusion System, which is intended for ... achieving fusion in conjunction with bone graft. The U.S. ... to the OCTAVE System last month. ...
Cached Medicine Technology:Reportlinker Adds Global Generic Pharmaceuticals Industry Report 2Reportlinker Adds Global Generic Pharmaceuticals Industry Report 3Reportlinker Adds Global Generic Pharmaceuticals Industry Report 4Reportlinker Adds Global Generic Pharmaceuticals Industry Report 5Reportlinker Adds Global Generic Pharmaceuticals Industry Report 6Reportlinker Adds Global Generic Pharmaceuticals Industry Report 7
... T is a quadripolar pacing ... pacing and monitoring during and ... 227 T features tines for ... allows safe and easy implantation ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: